"Bronchodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
| Descriptor ID |
D001993
|
| MeSH Number(s) |
D27.505.696.663.050.110 D27.505.954.796.050.100
|
| Concept/Terms |
Bronchodilator Agents- Bronchodilator Agents
- Agents, Bronchodilator
- Bronchial-Dilating Agents
- Agents, Bronchial-Dilating
- Bronchial Dilating Agents
- Bronchodilators
Broncholytic Effect- Broncholytic Effect
- Effect, Broncholytic
- Broncholytic Effects
- Effects, Broncholytic
Bronchodilator Effect- Bronchodilator Effect
- Effect, Bronchodilator
- Bronchodilator Effects
- Effects, Bronchodilator
|
Below are MeSH descriptors whose meaning is more general than "Bronchodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Bronchodilator Agents".
This graph shows the total number of publications written about "Bronchodilator Agents" by people in this website by year, and whether "Bronchodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 3 | 0 | 3 |
| 2006 | 2 | 2 | 4 |
| 2008 | 1 | 2 | 3 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 1 | 4 |
| 2014 | 1 | 2 | 3 |
| 2015 | 1 | 0 | 1 |
| 2017 | 0 | 3 | 3 |
| 2018 | 1 | 2 | 3 |
| 2019 | 3 | 4 | 7 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 1 | 2 | 3 |
| 2023 | 1 | 2 | 3 |
| 2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bronchodilator Agents" by people in Profiles.
-
Reduced Cost Sharing and Medication Management Services for COPD: A Randomized Clinical Trial. JAMA Intern Med. 2024 Oct 01; 184(10):1186-1194.
-
Real-world treatment trajectories of adults with newly diagnosed asthma or COPD. BMJ Open Respir Res. 2024 02 27; 11(1).
-
A comparative examination of morphine and fentanyl: unravelling the differential impacts on breathing and airway stability. J Physiol. 2023 10; 601(20):4625-4642.
-
Management Practices for Standard-Risk and High-Risk Patients With Bronchiolitis. Hosp Pediatr. 2023 09 01; 13(9):833-840.
-
A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma. Am J Respir Crit Care Med. 2023 02 15; 207(4):390-405.
-
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD. Chest. 2023 03; 163(3):502-514.
-
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function. N Engl J Med. 2022 09 29; 387(13):1173-1184.
-
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med. 2022 09 01; 206(5):554-562.
-
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma. Lancet Child Adolesc Health. 2021 12; 5(12):862-872.
-
A Practical Guide to Implementing SMART in Asthma Management. J Allergy Clin Immunol Pract. 2022 01; 10(1S):S31-S38.